TLDR Biotech

Investor Due Diligence Report

by Christian Cuchapin

beehiivSports

Daily coverage of the biotech and pharma industry, straight to your inbox and all in one skimmable email.

View full profile →Download PDF

Key Metrics

Subscribers

Medium confidence

Weekly Growth

~0%

Subscriber count is a platform estimate

Quality & Publishing

Audience Quality Score

54Fair

0100

Publishing Pace

~5x per week

4.8 posts/week

Publishing Consistency

86/100

Very Consistent (~1.5d avg)

Component	Score	Weight
Publishing Consistency	82/100	10%

Competitive Landscape (Sports)

Newsletter	Subscribers	Weekly Growth	Price	Platform
the Daily Briefing	173K	N/A	$5/mo	substack
The Hockey Writers - NHL News, Rumors & Opinion	39K	N/A	$7.77/mo	substack
Football Film Room	28K	N/A	$7/mo	substack
Split Zone Duo	19K	N/A	$10/mo	substack

Risk Assessment

Key risk factors for due diligence

Medium

Platform Dependency

Uses beehiiv platform

Low

Publishing Consistency

Regular publishing schedule

Medium

Key Person

Single-author publication — key-person dependency

High

Revenue Model

Pre-monetization — no paid subscription tier

Monetization Readiness

Readiness for paid subscriptions

Subscriber threshold

3K subscribers — above the 2K category median for first paid tier

Has paid tier

No paid subscription tier yet

Peer monetization

100% of 88 similar-size peers in Sports have paid tiers

Data Quality

Report Data QualityLimited - Key metrics unavailable

Subscriber Confidencemedium

Disclaimer: This report is generated automatically based on publicly available data and proprietary estimation models. Estimated subscriber counts are derived from engagement patterns and should be verified through direct disclosure. Revenue estimates are based on known pricing and estimated paid subscriber counts. This report is for informational purposes only and should not be the sole basis for investment decisions.